SPOREsBreastCoresCore 2 – Clinical StudiesActivities:
The Core facilitates all SPORE-related clinical research across DFCI/BWH, BIDMC and MGH. These institutions see over 4,000 new patients with breast cancer each year, and well over 10,000 patients are seen for ongoing therapy and or follow-up visits. All SPORE investigators conducting clinical trials or other research studies involving human subjects will utilize the services of this Core. The Core works to minimize delays in the activation of protocols and to streamline patient recruitment and consent studies across multiple institutions. With the complexity of this clinical environment, the Core will provide an overarching structure that eliminates the need to create individual project-based study teams in each of the participating institutions. Sourcing Tissue
Key PersonnelEric P. Winer, MD – DFCI |
||